https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg 0 0 2013-11-06 / Oncoimmunology 2013 Dec;2(12):e27059 https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg 2013-11-06 / Oncoimmunology 2013 Dec;2(12):e270592013-11-06 00:00:002021-11-15 13:33:23Dendritic cell-based immunotherapy in ovarian cancer
Dendritic cell-based immunotherapy in ovarian cancer
Worldwide, 80% of patients with ovarian cancer die of the disease. New treatments for this aggressive disease are therefore being intensively searched. Although dendritic cell-based vaccines against gynecological malignancies are in their infancy, this immunotherapeutic approach holds much promise. Here, we present our view on an optimal dendritic cell-based immunotherapeutic strategy against ovarian cancer.